NCT00361166View on ClinicalTrials.gov

Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone

PHASE2CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

March 31, 2007

Conditions
Schizophrenia
Interventions
DRUG

ACP-103

Trial Locations (17)

20016

Washington D.C.

63118

St Louis

75062

Irving

78756

Austin

90660

Pico Rivera

90703

Cerritos

90723

Paramount

91206

Glendale

92123

San Diego

92126

San Diego

92845

Garden Grove

40325-090

Salvador

74922-810

Aparecida de Goiânia

80430-050

Curitiba

80520-000

Curitiba

21020-130

Rio de Janeiro

05403-010

São Paulo

Sponsors
All Listed Sponsors
lead

ACADIA Pharmaceuticals Inc.

INDUSTRY